Results 101 to 110 of about 2,738 (166)

Flaxseed (Linum Usitatissimum L.) Supplementation in Patients Undergoing Lipoprotein Apheresis for Severe Hyperlipidemia-A Pilot Study. [PDF]

Nutrients, 2020
Kanikowska D, Korybalska K, Mickiewicz A, Rutkowski R, Kuchta A, Sato M, Kreft E, Fijałkowski M, Gruchała M, Jankowski M, Bręborowicz A, Witowski J.   +11 more
europepmc   +1 more source

Lipoprotein Apheresis Alleviates Treatment-Resistant Peripheral Artery Disease Despite the Normal Range of Atherogenic Lipoproteins: The LETS-PAD Study. [PDF]

J Atheroscler Thromb
Ueda E, Ishiga K, Wakui H, Kawai Y, Kobayashi R, Kinguchi S, Kanaoka T, Saigusa Y, Mikami T, Yabuki Y, Goda M, Machida D, Fujita T, Haruhara K, Sugano T, Azushima K, Toya Y, Tamura K.   +17 more
europepmc   +1 more source

Cardiovascular outcomes in patients with homozygous familial hypercholesterolaemia on lipoprotein apheresis initiated during childhood: long-term follow-up of an international cohort from two registries. [PDF]

Lancet Child Adolesc Health
Reijman MD, Tromp TR, Hutten BA, Hovingh GK, Blom DJ, Catapano AL, Cuchel M, Dann EJ, Gallo A, Hudgins LC, Raal FJ, Ray KK, Sadiq F, Soran H, Groothoff JW, Wiegman A, Kusters DM, Homozygous Familial Hypercholesterolaemia International Clinical Collaborators (HICC), Children with Homozygous Hypercholesterolemia on Lipoprotein Apheresis: an International Registry (CHAIN) consortia.   +18 more
europepmc   +1 more source

Low-density lipoprotein apheresis for PLA2R-related membranous glomerulonephritis accompanied by IgG4-related tubulointerstitial nephritis. [PDF]

CEN Case Rep, 2020
Nishizawa Y, Honda K, Aoyama Y, Hosoda Y, Tamura T, Horimoto A, Omae K, Higuchi C, Sakura H, Nitta K, Ogawa T.   +10 more
europepmc   +1 more source

Low-density Lipoprotein Receptor Activities, Lipids, Apolipoprotein, and Clinical Course of Patients with Steroid-resistant Nephrotic Syndrome Treated with Low-density Lipoprotein Apheresis: A Case Series. [PDF]

Intern Med
Shima H, Higashiguchi Y, Doi T, Harada M, Okamoto T, Inoue T, Tashiro M, Okada K, Minakuchi J.   +8 more
europepmc   +1 more source

Low-Density Lipoprotein Apheresis in Patients with Acute Kidney Injury Due to Minimal Change Disease Requiring Acute Renal Replacement Therapy. [PDF]

Int J Nephrol Renovasc Dis, 2020
Terada K, Mugishima K, Kawasaki S, Itagaki F, Yamada T, Sakai Y.   +5 more
europepmc   +1 more source

Activation of Lipid Mediator Formation Due to Lipoprotein Apheresis. [PDF]

Nutrients, 2019
Weylandt KH, Schmöcker C, Ostermann AI, Kutzner L, Willenberg I, Kiesler S, Steinhagen-Thiessen E, Schebb NH, Kassner U.   +8 more
europepmc   +1 more source

Long-term lipoprotein apheresis in the treatment of severe familial hypercholesterolemia refractory to high intensity statin therapy: Three year experience at a lipoprotein apheresis centre. [PDF]

Cardiol J, 2019
Mickiewicz A, Borowiec-Wolna J, Bachorski W, Gilis-Malinowska N, Gałąska R, Raczak G, Chmara M, Wasąg B, Jaguszewski MJ, Fijałkowski M, Gruchała M.   +10 more
europepmc   +1 more source

Lipoprotein Apheresis Acutely Reverses Coronary Microvascular Dysfunction in Patients With Severe Hypercholesterolemia. [PDF]

JACC Cardiovasc Imaging, 2019
Wu MD, Moccetti F, Brown E, Davidson BP, Atkinson T, Belcik JT, Giraud G, Duell PB, Fazio S, Tavori H, Tsimikas S, Lindner JR.   +11 more
europepmc   +1 more source

Current Role of Lipoprotein Apheresis in the Treatment of High-Risk Patients. [PDF]

J Cardiovasc Dev Dis, 2018
Julius U.
europepmc   +1 more source